DGAP-News
Agennix AG Announces Liquidation - Seite 2
that it is no longer probable that we will be achieving a transaction in
the timeframe required.' Torsten Hombeck continued: 'Unfortunately our cash
position is such that we have asked our shareholders to approve the
liquidation of Agennix AG, the public entity. This is a difficult step for
us to take, but we believe it is the only right one given the situation of
the Company.'
About Agennix
Agennix AG is a publicly listed biopharmaceutical company. The Company's
clinical development programs include oral talactoferrin alfa; a topical
gel form of talactoferrin and RGB-286638, a multi-targeted kinase
inhibitor. Agennix's registered seat is in Heidelberg, Germany. The
Company's site of operation is in Princeton, New Jersey. For additional
information, please visit the Agennix website at www.agennix.com.
This press release contains forward-looking statements, which express the
current beliefs and expectations of the management of Agennix AG. Such
statements are based on current expectations and are subject to risks and
uncertainties, many of which are beyond our control, that could cause
future results, performance or achievements to differ significantly from
those expressed or implied by such forward-looking statements. Actual
results could differ materially depending on a number of factors, and we
caution investors not to place undue reliance on the forward-looking
statements contained in this press release. There can be no guarantee that
the Company will have or be able to obtain additional financial resources
to avoid insolvency or bankruptcy. Forward-looking statements speak only as
of the date on which they are made and Agennix undertakes no obligation to
update these forward-looking statements, even if new information becomes
available in the future.
Agennix(R) is a trademark of Agennix AG.
For further information, please contact:
Barbara Mueller
Manager, Investor Relations & Corporate Communications
Phone: +49 (0)89 90 40 5464
ir@agennix.com
End of Corporate News
---------------------------------------------------------------------
23.05.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Agennix AG
Im Neuenheimer Feld 515
69120 Heidelberg
Germany
Phone: +49 (0)89 90 405 464
Fax: +49 (0)89 90 405 811
E-mail: ir@agennix.com
Internet: www.agennix.com
ISIN: DE000A1A6XX4
WKN: A1A6XX
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,
München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
212669 23.05.2013
current beliefs and expectations of the management of Agennix AG. Such
statements are based on current expectations and are subject to risks and
uncertainties, many of which are beyond our control, that could cause
future results, performance or achievements to differ significantly from
those expressed or implied by such forward-looking statements. Actual
results could differ materially depending on a number of factors, and we
caution investors not to place undue reliance on the forward-looking
statements contained in this press release. There can be no guarantee that
the Company will have or be able to obtain additional financial resources
to avoid insolvency or bankruptcy. Forward-looking statements speak only as
of the date on which they are made and Agennix undertakes no obligation to
update these forward-looking statements, even if new information becomes
available in the future.
Agennix(R) is a trademark of Agennix AG.
For further information, please contact:
Barbara Mueller
Manager, Investor Relations & Corporate Communications
Phone: +49 (0)89 90 40 5464
ir@agennix.com
End of Corporate News
---------------------------------------------------------------------
23.05.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Agennix AG
Im Neuenheimer Feld 515
69120 Heidelberg
Germany
Phone: +49 (0)89 90 405 464
Fax: +49 (0)89 90 405 811
E-mail: ir@agennix.com
Internet: www.agennix.com
ISIN: DE000A1A6XX4
WKN: A1A6XX
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,
München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
212669 23.05.2013
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte